Hudson Bay Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-110,000
| Closed | -$2.22M | – | 1294 |
|
|
2021
Q3 | $2.22M | Buy |
110,000
+25,024
| +29% | +$505K | 0.03% | 582 |
|
|
2021
Q2 | $3.17M | Sell |
84,976
-80,024
| -48% | -$2.99M | 0.04% | 471 |
|
|
2021
Q1 | $4.22M | Sell |
165,000
-5,000
| -3% | -$128K | 0.05% | 338 |
|
|
2020
Q4 | $3.75M | Sell |
170,000
-160,000
| -48% | -$3.52M | 0.04% | 268 |
|
|
2020
Q3 | $5.94M | Buy |
330,000
+120,000
| +57% | +$2.16M | 0.09% | 193 |
|
|
2020
Q2 | $5.33M | Buy |
+210,000
| New | +$5.33M | 0.09% | 180 |
|